Activest Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103K Buy
998
+745
+294% +$66.5K 0.02% 184
2026
Q1
$18.2K Sell
253
-39
-13% -$3K ﹤0.01% 549
2025
Q4
$23.2K Buy
292
+46
+19% +$3.63K ﹤0.01% 475
2025
Q3
$18.5K Buy
246
+61
+33% +$4.18K ﹤0.01% 396
2025
Q2
$12.8K Sell
185
-109
-37% -$7.15K ﹤0.01% 386
2025
Q1
$19.9K Buy
294
+290
+7,250% +$17.4K 0.01% 297
2024
Q4
$180 Buy
+4
New +$224 ﹤0.01% 648
2024
Q2
Sell
-68
Closed -$4.25K 531
2024
Q1
$5.42K Sell
68
-1
-1% -$76 ﹤0.01% 251
2023
Q4
$5.45K Sell
69
-6
-8% -$427 ﹤0.01% 224
2023
Q3
$5.25K Hold
75
﹤0.01% 221
2023
Q2
$5.64K Sell
75
-15
-17% -$1.07K ﹤0.01% 210
2023
Q1
$6.73K Buy
+90
New +$7.55K ﹤0.01% 194
2022
Q3
Sell
-84
Closed -$8K 475
2022
Q2
$8K Hold
84
0.01% 212
2022
Q1
$9K Buy
84
+16
+24% +$1.68K 0.01% 209
2021
Q4
$7K Hold
68
﹤0.01% 230
2021
Q3
$6K Hold
68
﹤0.01% 267
2021
Q2
$6K Hold
68
﹤0.01% 242
2021
Q1
$5K Buy
+68
New +$4.95K ﹤0.01% 232

Other funds holding CVS

Activest Wealth Management's CVS Position: Q2 2026 in Review

Activest Wealth Management increased its CVS Health (CVS) stake by 294% in Q2 2026, buying an estimated $66.5K and bringing the position to 998 shares worth $103K. The position accounts for 0.02% of the portfolio, ranked #184.

Activest Wealth Management first reported a position in CVS in Q1 2021 and has held it in 18 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Activest Wealth Management held 998 shares of CVS Health worth $103K as of Q2 2026.
  • Activest Wealth Management bought 745 CVS Health shares in Q2 2026, an estimated $66.5K.
  • CVS Health made up 0.02% of Activest Wealth Management's portfolio in Q2 2026, its #184 holding.
  • Activest Wealth Management first reported a position in CVS Health in Q1 2021 and has held it in 18 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.